Ondine Biomedical Inc. (OBI.L) LSE

8.75

+0.15(+1.74%)

Updated at December 24 10:12AM

Currency In GBp

Valuation

Market Cap43.23M
Enterprise Value33.63M
P/E Ratio-3.46
PEG Ratio-0.03
Price/Sales Ratio45.22
Price/Book Ratio7.13
Enterprise/Revenue38.96
Enterprise/EBITDA-5.74

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-9.25
Operating Margin-9.4

Management Effectiveness

Return On Assets-1.11
Return On Equity-4.11

Income Statement

Revenue2.05M
Revenue/Share0.01
Gross Profit1.32M
EBITDA-18.49M
Net Income-19.1M
Diluted EPS-0.07

Balance Sheet

Total Cash9.77M
Total Cash/Share0.03
Total Debt168,000
Total Debt/Equity0.02
Current Ratio2.05
Book Value Per Share0.02

Price History

52-Week Change2.94
52-Week High18.5
52-Week Low8
Moving Average 50 Days11.59
Moving Average 200 Days12.05

Statistics

Average Volume166,908
Shares Outstanding428.31M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A